TY  - GEN
AU  - Paganin,M
AU  - Zecca,M
AU  - Fabbri,G
AU  - Polato,K
AU  - Biondi,A
AU  - Rizzari,C
AU  - Locatelli,F
AU  - Basso,G
TI  - Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia
SN  - 1476-5551
PY  - 2009///0127
KW  - Adolescent
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Asparaginase
KW  - Child
KW  - Child, Preschool
KW  - Combined Modality Therapy
KW  - Cyclophosphamide
KW  - Cytarabine
KW  - Daunorubicin
KW  - Disease-Free Survival
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Infant
KW  - Male
KW  - Mercaptopurine
KW  - Methotrexate
KW  - Multivariate Analysis
KW  - Neoplasm, Residual
KW  - drug therapy
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - Predictive Value of Tests
KW  - Prednisone
KW  - Prognosis
KW  - Prospective Studies
KW  - Recurrence
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Risk Factors
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Vincristine
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/leu.2008.227
ER  -